NR 546
MIDTERM EXAM
Expected Questions with Answers
(Advanced Psychopharmacology for the PMHNP)
Chamberlain
What You Will Get:
Instant PDF download
multiple-choice questions
Verified answers included
Detailed rationales for review
Advanced Psychopharmacology for the PMHNP focused
Great for Midterm exam review and self-study
Please note: This is an independent study resource and is not affiliated
with or endorsed by Chamberlain University.
,Contents
NR 546 Midterm Exam ................................................2
NR 546 Midterm Exam Review .................................30
NR 546 Midterm Exam
1. A 22-year-old patient recently diagnosed with bipolar disorder states, "I'm not
crazy," and is refusing to take his prescribed medication. Which type of factor is
contributing to this patient's nonadherence?
A. Client factors
B. Clinician factors
C. Structural factors
D. Environmental factors
Correct Answer: A. Client factors
Expert Rationale: Nonadherence driven by denial of illness, stigma, lack of insight, or
personal beliefs is classified as a client factor. Structural factors refer to systemic barriers
such as cost, insurance gaps, pharmacy access, or transportation. The patient's refusal
stems from internal cognitive and attitudinal barriers (poor insight into bipolar disorder),
making this a client-level barrier requiring psychoeducation and motivational
interviewing.
2. Using Dell'Osso et al.'s sequential framework of priorities to promote medication
adherence, determine which step is being defined: The PMHNP explains the
mechanism of action, anticipated time to experience effects, side effects, and lifestyle
instructions to a patient after prescribing.
,A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
Correct Answer: B. Medication education
Expert Rationale: Dell'Osso's sequential framework emphasizes structured
psychoeducation as a prerequisite for adherence. Explaining onset of action (e.g., 2–4
weeks for SSRIs), common adverse effects, and lifestyle considerations (diet, alcohol, sun
exposure) empowers the patient to tolerate early side effects and recognize therapeutic
delays, preventing premature discontinuation.
3. A patient recovering from a stroke has trouble with speech comprehension and
works with a speech therapist twice a week. Which part of the patient's brain has
been affected by the stroke?
A. The Broca's area
B. The Basal ganglia
C. The Limbic system
D. The Wernicke's area
Correct Answer: D. The Wernicke's area
Expert Rationale: Wernicke's area (superior temporal gyrus, dominant hemisphere)
governs receptive language comprehension. Damage produces fluent but nonsensical
speech with poor comprehension (Wernicke's aphasia). Broca's area (option A) governs
expressive language; patients with Broca's aphasia understand language but cannot
speak fluently.
4. Which of the following poses a potential ethical concern when prescribing
psychiatric medications?
A. The patient is homeless and uninsured
B. The patient poses a risk to themself as they state they are experiencing very scary
auditory and visual hallucinations
, C. The patient's family voices a stigma against psychiatric medications
D. The patient states they worry about the potential side effects of the medication
Correct Answer: B. The patient poses a risk to themself as they state they are
experiencing very scary auditory and visual hallucinations
Expert Rationale: Acute safety concerns (command hallucinations, suicidal ideation, or
imminent danger) trigger the duty to protect and may necessitate involuntary
treatment, emergency hold, or hospitalization. While options A, C, and D represent
access barriers, cultural issues, and informed consent concerns respectively, option B
represents an immediate ethical-legal crisis requiring assessment for involuntary
commitment and protective intervention.
5. What is the name of the lobe that controls visual processing?
A. Gyrus
B. Frontal Lobe
C. Occipital Lobe
D. Parietal Lobe
Correct Answer: C. Occipital Lobe
Expert Rationale: The occipital lobe contains the primary visual cortex (V1, Brodmann
area 17) and associative visual areas (V2–V5). Lesions produce visual field deficits,
agnosias, or cortical blindness. The parietal lobe (option D) processes visuospatial
integration, while the frontal lobe (option B) governs executive function and motor
planning.
6. The cerebellum, cerebrum, brain stem, and butterfly-shaped portion of the central
spinal cord are comprised of _____________, which contains neural cell bodies, axon
terminals, dendrites, and all nerve synapses.
A. Frontal lobe
B. White matter
C. Grey matter
D. Corpus callosum
MIDTERM EXAM
Expected Questions with Answers
(Advanced Psychopharmacology for the PMHNP)
Chamberlain
What You Will Get:
Instant PDF download
multiple-choice questions
Verified answers included
Detailed rationales for review
Advanced Psychopharmacology for the PMHNP focused
Great for Midterm exam review and self-study
Please note: This is an independent study resource and is not affiliated
with or endorsed by Chamberlain University.
,Contents
NR 546 Midterm Exam ................................................2
NR 546 Midterm Exam Review .................................30
NR 546 Midterm Exam
1. A 22-year-old patient recently diagnosed with bipolar disorder states, "I'm not
crazy," and is refusing to take his prescribed medication. Which type of factor is
contributing to this patient's nonadherence?
A. Client factors
B. Clinician factors
C. Structural factors
D. Environmental factors
Correct Answer: A. Client factors
Expert Rationale: Nonadherence driven by denial of illness, stigma, lack of insight, or
personal beliefs is classified as a client factor. Structural factors refer to systemic barriers
such as cost, insurance gaps, pharmacy access, or transportation. The patient's refusal
stems from internal cognitive and attitudinal barriers (poor insight into bipolar disorder),
making this a client-level barrier requiring psychoeducation and motivational
interviewing.
2. Using Dell'Osso et al.'s sequential framework of priorities to promote medication
adherence, determine which step is being defined: The PMHNP explains the
mechanism of action, anticipated time to experience effects, side effects, and lifestyle
instructions to a patient after prescribing.
,A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
Correct Answer: B. Medication education
Expert Rationale: Dell'Osso's sequential framework emphasizes structured
psychoeducation as a prerequisite for adherence. Explaining onset of action (e.g., 2–4
weeks for SSRIs), common adverse effects, and lifestyle considerations (diet, alcohol, sun
exposure) empowers the patient to tolerate early side effects and recognize therapeutic
delays, preventing premature discontinuation.
3. A patient recovering from a stroke has trouble with speech comprehension and
works with a speech therapist twice a week. Which part of the patient's brain has
been affected by the stroke?
A. The Broca's area
B. The Basal ganglia
C. The Limbic system
D. The Wernicke's area
Correct Answer: D. The Wernicke's area
Expert Rationale: Wernicke's area (superior temporal gyrus, dominant hemisphere)
governs receptive language comprehension. Damage produces fluent but nonsensical
speech with poor comprehension (Wernicke's aphasia). Broca's area (option A) governs
expressive language; patients with Broca's aphasia understand language but cannot
speak fluently.
4. Which of the following poses a potential ethical concern when prescribing
psychiatric medications?
A. The patient is homeless and uninsured
B. The patient poses a risk to themself as they state they are experiencing very scary
auditory and visual hallucinations
, C. The patient's family voices a stigma against psychiatric medications
D. The patient states they worry about the potential side effects of the medication
Correct Answer: B. The patient poses a risk to themself as they state they are
experiencing very scary auditory and visual hallucinations
Expert Rationale: Acute safety concerns (command hallucinations, suicidal ideation, or
imminent danger) trigger the duty to protect and may necessitate involuntary
treatment, emergency hold, or hospitalization. While options A, C, and D represent
access barriers, cultural issues, and informed consent concerns respectively, option B
represents an immediate ethical-legal crisis requiring assessment for involuntary
commitment and protective intervention.
5. What is the name of the lobe that controls visual processing?
A. Gyrus
B. Frontal Lobe
C. Occipital Lobe
D. Parietal Lobe
Correct Answer: C. Occipital Lobe
Expert Rationale: The occipital lobe contains the primary visual cortex (V1, Brodmann
area 17) and associative visual areas (V2–V5). Lesions produce visual field deficits,
agnosias, or cortical blindness. The parietal lobe (option D) processes visuospatial
integration, while the frontal lobe (option B) governs executive function and motor
planning.
6. The cerebellum, cerebrum, brain stem, and butterfly-shaped portion of the central
spinal cord are comprised of _____________, which contains neural cell bodies, axon
terminals, dendrites, and all nerve synapses.
A. Frontal lobe
B. White matter
C. Grey matter
D. Corpus callosum
